Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
7 Hills Pharma, LLC
Incyte Corporation
Incyte Corporation
Children's National Research Institute
Xencor, Inc.
Incyte Corporation